Research Article| Volume 11, ISSUE 4, P361-372, August 1983

Role of renin release in the hemodynamic, renal and dipsogenic actions of the prostacyclin analogue CG 4203 in conscious rats

      This paper is only available as a PDF. To read, Please Download here.


      The influence of CG 4203, a chemically and metabolically stable prostacyclin analogue, on plasma renin activity, arterial blood pressure, renal function and water intake was investigated in conscious rats. CG 4203 infused intravenously starting at 1 μg·kg−1·min−1 induced both a fall in blood pressure and an increase of plasma renin activity. The angiotensin II antagonist saralasine infused simultaneously intensified the hypotensive effect of CG 4203 (1.0 μg·kg−1·min−1. Within a similar dose range CG 4203 dose-dependently inhibited diuresis and saluresis and reduced the urinary sodium/potassium ratio. These effects were partially reversed by adrenalectomy and completely abolished by pretreatment with the angiotensin I converting enzyme inhibitor captopril. Similarly, CG 4203 (0.21 – 4.64 μg·kg−1·min−1 ) dose-dependently caused increased water intake which was prevented by previous nephrectomy. In conclusion, it is demonstrated that CG 4203 like prostacyclin itself already at hypotensive threshold dosages stimulates a functionally relevant renin release. The activation of the renin-angiotensin-aldosterone system attenuates the intrinsic hypotensive effects of CG 4203. The antidiuretic and dipsogenic efficacy of CG 4203 can also be attributed to renin-dependent angiotensin II formation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Schölkens B.A.
        Plasmarenin activity and vasodepressor action of prostacyclins with modified -side chain in anaesthetized rats.
        Prostaglandins and Medicine. 1980; 4: 357
        • Franco-Saenz R.
        • Suzuki S.
        • Tan S.Y.
        Prostaglandins and renin production: a review.
        Prostaglandins. 1980; 20: 1131
        • Seipp U.
        • Michel G.
        • Loschen G.
        • Kim S.-M.A.
        • Vollenberg W.
        • Frankus E.
        • Flohé L.
        Structure-activity relationship of PGI2 analogs.
        in: 1st Intern. Austrian Prostaglandin Meeting, Bad Ischl1982
        • Michel G.
        • Wilsmann K.
        CG 4203 (New stable prostacyclin analogue): effect on bleeding time and blood coagulation.
        in: 1st Intern. Austrian Prostaglandin Meeting, Bad Ischl1982
        • Michel G.
        • Friderichs E.
        • Müller B.
        • Wilsmann K.
        • Seipp U.
        • Flohé L.
        CG 4203 (New stable prostacyclin analogue): actions on platelets and blood pressure.
        in: 1st Intern. Austrian Prostaglan din Meeting, Bad Ischl1982
        • Müller B.
        • Wilsmann K.
        CG 4203 (New stable prostacyclin analogue): cardiovascular profile in anaesthetized rabbits.
        in: 1st Intern. Austrian Prostaglandin Meeting, Bad Ischl1982
        • Haber E.
        • Koerner T.
        • Page L.B.
        • Kliman B.
        • Purnode A.
        Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.
        J. Clin. Endocrinol. Metab. 1969; 29: 1349
        • Weeks J.R.
        • Compton L.D.
        The cardiovascular pharmacology of prostacyclin in the rat.
        Prostaglandins. 1979; 17: 501
        • Hall J.E.
        • Guyton A.C.
        • Salgado H.C.
        • McCaare
        • Malfe J.W.
        Renal hemodynamics in acute and chronic angiotensin II hypertension.
        Am. J. Physiol. 1978; 236: F174
        • Lohmeier T.E.
        • Cowley A.W.
        Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog.
        Circ. Res. 1979; 44: 154
        • Hashimoto T.
        Effects of prostaglandin E2, I2 and F on systemic and renal hemodynamics, renal function and renin secretion in anesthetized dogs.
        Japan. J. Pharmacol. 1980; 30: 173
        • Fitzsimons J.T.
        Physiol. Rev. 1972; 52: 468
        • Fitzsimons J.T.
        The renin angiotensin system and drinking behaviour.
        Progr. Brain Res. 1975; 42: 215
        • Keeton T.K.
        • Campbell W.B.
        The pharmacologic alteration of renin release.
        Pharmacol. Rev. 1981; 31: 81
        • Whorton A.R.
        • Misono K.
        • Hollifield J.
        • Frölich J.C.
        Prostaglandins and renin release: I. Stimulation of renin release from rabbit renal cortical slices by PGI2.
        Prostaglandins. 1977; 14: 1095